Trial Profile
Phase 1 study in Japan for oral TREAKISYM® in patients with progressive solid tumors
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 May 2018
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 28 May 2018 According to a SymBio Pharmaceuticals media release, first patient has been dosed.
- 23 Jan 2018 New trial record